valproate + cytidine-containing drug

This is a combination of valproate (or its forms such as valproic acid, sodium valproate, or semisodium) with a cytidine-containing drug. Valproate is primarily used to treat epilepsy and bipolar disorder and may also be used for migraine prophylaxis. Its mechanism of action includes increasing GABAergic activity, inhibiting voltage-gated sodium channels, and possibly modulating histone deacetylase activity[1][2][4]. Cytidine-containing drugs typically refer to compounds that include the nucleoside cytidine or its derivatives; these are not standard antiepileptic or mood-stabilizing agents but may be investigated for neuroprotective or other effects in research settings. There is no widely recognized pharmaceutical product combining these two classes as a single marketed therapy.

Other names

valproic acid + cytidinesodium valproate + cytidinevalproate semisodium + cytidine